GSK, Alector enter USD 2.2 billion deal for Parkinson's, Alzheimer's drugs Ruchika Sharma5 July 2021 11:00 AM ISTUK: GlaxoSmithKline Plc and U.S. firm Alector Inc will together develop antibody-based treatments for Parkinson's, Alzheimer's and other similar...
NPPA Fixes Ceiling Price Of thyroid drug Levothyroxine Medical Dialogues Team5 May 2021 11:00 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
GSK cancer drug JEMPERLI gets speedy USFDA approval Ruchika Sharma25 April 2021 9:30 AM ISTLondon: GlaxoSmithKline plc has recently announced that the US Food and Drug Administration (USFDA) has approved JEMPERLI (dostarlimab-gxly), a...
GSK to sell Vemgal plant to Hetero Labs for Rs 180 crore Ruchika Sharma2 April 2021 12:14 PM ISTNew Delhi: Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday said its board has approved the sale of its manufacturing facility located at Vemgal...
GSK gets EMA panel recommendation to approve Benlysta for adult patients with active lupus nephritis Ruchika Sharma29 March 2021 9:30 AM ISTUK: GlaxoSmithKline plc (GSK) has recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
GSK, Vir Biotechnology submit EUA request to USFDA for VIR-7831 for early Covid-19 treatment Ruchika Sharma28 March 2021 10:30 AM ISTLondon and San Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced the submission of an application to the U.S. Food...
GSK, Vir Biotechnology expand coronavirus collaboration to include new therapies including influenza Ruchika Sharma20 Feb 2021 9:30 AM ISTLondon: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced they have signed a binding agreement to expand their existing...
Setback: Merck, GSK lung cancer drug bintrafusp alfa fails early lead trial Hina Zahid21 Jan 2021 10:00 AM ISTThe failure also puts a damper on the oncology ambitions of Britain's GlaxoSmithKline, which is co developing the drug with Merck under a 2019...
Sanofi to announce COVID vaccine price in development with GSK post Phase 1, 2 trial results Ruchika Sharma7 Dec 2020 10:30 AM ISTParis: French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has...
Speciality care, vaccines sale prompts Sanofi to raise outlook Ruchika Sharma31 Oct 2020 9:00 AM ISTParis: Sanofi raised its 2020 earnings guidance for the second time this year after posting slightly stronger-than-expected third-quarter results...
GSK to launch final testing of respiratory syncytial virus vaccine Ruchika Sharma21 Oct 2020 11:00 AM ISTGSK said Phase III studies, with the potential to produce data for regulatory approval, would likely start over the coming months.
GSK, Sanofi to provide 300 million doses of COVID-19 vaccine to EU Ruchika Sharma19 Sept 2020 1:15 PM ISTA Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.
